In re Bristol-Myers Squibb Securities Litigation
Not only did we obtain a $185 million settlement, but also secured corporate governance reforms that affect future Bristol-Myers Squibb consumers and investors.
After prosecuting the securities litigation claims against Bristol-Myers Squibb Co. ("BMS") for over five years, Labaton Sucharow, lead counsel representing the class and lead plaintiff, the LongView Collective Investment Fund of the Amalgamated Bank, reached an agreement in principle to settle the claims for $185 million in addition to meaningful corporate governance reforms that will affect future consumers and investors alike. The class action settlement concludes a lengthy and arduous litigation that was set for trial in 2006.
For more information, please click here.